UmBio
Ume├Ñ · Founded 2002
About UmBio
UmBio AB is a leading player in multivariate image analysis and they are known to provide a broad range of hardware and software products within this field. UmBio is based in Sweden and current customers include Merck, Danisco, Mirka, NeuroSearch, Pfizer, VTT and Arla. UmBio Evince Image, the company's multivariate image analysis software, is a versatile analytical tool that dramatically reduces the time required to reveal the value in online or lab data. UmBio Predict is UmBio’s new software and hardware for automatically predicting data from a given instrument in real-time, with an automatic high-performance calculation engine capable of 100% representation. UmBio Industry is a turn-key solution including sophisticated hardware and software solutions to allow the measurement of hundreds of wavelengths in real time with a high throughput hyperspectral camera. This generates high quality spectral data which is automatically analysed continuously in real time. On October 21st, 2009 UmBio recieved 1st Prize in the Metro Tech Challenge, a Swedish competition of startup companies arranged by SiSP and MetroTeknik. The associated press release states, "The jury considers UmBio to be a great example of successful entrepreneurship, together with a positive development of the organization, technology, products and market. UmBio seems to have the true possibility to penetrate an international process market. They are world leading pioneers within spectral image analysis, and provides next generation's quality control by offering chemical analysis in real time processes."
Company Facts
- Founded: 2002
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.2M
- Last round: Series Unknown (Jan 2011)
- Website: http://www.umbio.com/
- Phone: +46 90 15 48 20
Industries & Categories
Computer, Hardware, Software
Social Profiles
Canonical: https://fsome.com/organization/umbio-2267076 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.